BFRI has 36-month beta value of 0.47. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BFRI is 3.44M, and currently, short sellers hold a 1.12% ratio of that float. The average trading volume of BFRI on August 26, 2024 was 88.69K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BFRI) stock’s latest price update
The stock price of Biofrontera Inc (NASDAQ: BFRI) has dropped by -5.60 compared to previous close of 1.25. Despite this, the company has seen a fall of -13.24% in its stock price over the last five trading days. seekingalpha.com reported 2024-08-15 that Biofrontera Inc. (NASDAQ:BFRI ) Q2 2024 Earnings Conference Call August 15, 2024 10:00 AM ET Company Participants Andrew Barwicki – Barwicki Investor Relations Hermann Luebbert – CEO, Chairman and Founder Fred Leffler – CFO Conference Call Participants Jonathan Aschoff – ROTH MKM Bruce Jackson – The Benchmark Company Operator Good day, and welcome to the Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call. All participants will be in a listen-only mode.
BFRI’s Market Performance
Biofrontera Inc (BFRI) has seen a -13.24% fall in stock performance for the week, with a 7.27% gain in the past month and a 11.32% surge in the past quarter. The volatility ratio for the week is 12.11%, and the volatility levels for the past 30 days are at 11.99% for BFRI. The simple moving average for the past 20 days is -2.03% for BFRI’s stock, with a -31.65% simple moving average for the past 200 days.
BFRI Trading at 9.93% from the 50-Day Moving Average
After a stumble in the market that brought BFRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.62% of loss for the given period.
Volatility was left at 11.99%, however, over the last 30 days, the volatility rate increased by 12.11%, as shares sank -4.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.56% upper at present.
During the last 5 trading sessions, BFRI fell by -13.24%, which changed the moving average for the period of 200-days by -71.22% in comparison to the 20-day moving average, which settled at $1.2014. In addition, Biofrontera Inc saw -57.40% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BFRI
Current profitability levels for the company are sitting at:
- -0.54 for the present operating margin
- 0.47 for the gross margin
The net margin for Biofrontera Inc stands at -0.38. The total capital return value is set at -1.55. Equity return is now at value -149.41, with -46.20 for asset returns.
Based on Biofrontera Inc (BFRI), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -13.14. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 9.95.
Currently, EBITDA for the company is -20.29 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 0.1. The receivables turnover for the company is 10.05for trailing twelve months and the total asset turnover is 1.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.89.
Conclusion
To put it simply, Biofrontera Inc (BFRI) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
